These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 832270)

  • 1. Characterization and assay of progesterone receptor in human mammary carcinoma.
    Pichon MF; Milgrom E
    Cancer Res; 1977 Feb; 37(2):464-71. PubMed ID: 832270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of [3H]progesterone and [6,7-3H]-17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione for the measurement of progesterone receptors in human malignant tissue.
    Seematter RJ; Hoffman PG; Kuhn RW; Lockwood LC; Siiteri PK
    Cancer Res; 1978 Sep; 38(9):2800-6. PubMed ID: 679186
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics of progesterone-binding components in neoplastic mammary tissues of the rat.
    Goral JE; Wittliff JL
    Cancer Res; 1976 Jun; 36(6):1886-93. PubMed ID: 178435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding activity of 5alpha-reduced gestagens to the progestin receptor from African elephant (Loxodonta africana).
    Meyer HH; Jewgenow K; Hodges JK
    Gen Comp Endocrinol; 1997 Feb; 105(2):164-7. PubMed ID: 9038248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor assay in human mammary carcinoma with the synthetic estrogen 11beta-methoxy-17alpha-ethinyl-1,3,5(10)-estratriene-3,17beta-diol (R 2858).
    Okret S; Wrange O; Nordenskjöld B; Silfverswärd C; Gustafsson JA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3904-9. PubMed ID: 568028
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of binding components for progesterone and 5alpha-pregnane-3,20-dione in the hamster uterus.
    Leavitt WW; Grossman CJ
    Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4341-5. PubMed ID: 4373711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular binding of glucocorticoids in human mammary carcinoma.
    Fazekas AG; MacFarlane JK
    Cancer Res; 1977 Mar; 37(3):640-5. PubMed ID: 837365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
    Hurd C; Moudgil VK
    Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.
    Wittliff JL; Mehta RG; Boyd PA; Goral JE
    J Toxicol Environ Health Suppl; 1976; 1():231-56. PubMed ID: 186628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.
    Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S
    Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a progestin receptor in human benign prostatic hyperplasia and prostatic carcinoma.
    Gustafsson JA; Ekman P; Pousette A; Snochowski M; Högberg B
    Invest Urol; 1978 Mar; 15(5):361-6. PubMed ID: 76618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestin receptors in testes from various animal species.
    Seiki K; Fujii H; Kawamura N; Enomoto T; Haruki Y; Nakano M
    Tokai J Exp Clin Med; 1981 Oct; 6(4):343-51. PubMed ID: 7198833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of 8S progesterone receptor from human prostate in the presence of molybdate ion.
    Bevins CL; Bashirelahi N
    Cancer Res; 1980 Jul; 40(7):2234-9. PubMed ID: 7190061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
    Pasqualini JR; Chetrite G
    Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptors in mammary gland of the pregnant rat.
    Quirk SJ; Gannell JE; Funder JW
    Endocrinology; 1982 Dec; 111(6):1883-90. PubMed ID: 6890439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histochemical studies with an estrogen receptor-related protein in human breast tumors.
    Cano A; Coffer AI; Adatia R; Millis RR; Rubens RD; King RJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6475-80. PubMed ID: 3536082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Res; 1976 Dec; 36(12):4610-8. PubMed ID: 1000506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.